The advancement of pharmaceutical research and the development of novel therapeutic agents heavily rely on the availability of high-quality chemical intermediates. D-4-Chlorophenylalanine (CAS 14091-08-8) is one such compound, recognized for its utility in sophisticated chemical synthesis, particularly in peptide manufacturing. This article aims to inform B2B decision-makers and scientists about the significance of this chemical and how to best procure it.

D-4-Chlorophenylalanine is classified as a non-proteinogenic amino acid derivative, meaning it's not one of the standard 20 amino acids found in proteins. Its structure, featuring a chlorinated phenyl ring, imparts unique properties that are leveraged in specific applications. Primarily, it serves as a critical building block in solid-phase peptide synthesis (SPPS), a technique widely adopted in laboratories for constructing peptides used in drug discovery, diagnostics, and biochemical studies.

For research scientists and procurement managers, understanding the applications is the first step towards effective sourcing. If your research involves creating novel peptides for drug development, you will likely need to buy D-4-Chlorophenylalanine. The typical purity requirement for such applications is high, often exceeding 97%, to ensure the integrity of the synthetic process and the final peptide product.

When seeking a D-4-Chlorophenylalanine manufacturer, looking for suppliers in China can offer economic advantages. However, it is imperative to partner with a company that demonstrates stringent quality control and provides comprehensive product documentation. A reliable D-4-Chlorophenylalanine supplier will be transparent about their manufacturing processes and product specifications, including its appearance as a white to off-white powder.

Effective procurement of D-4-Chlorophenylalanine involves comparing prices from multiple sources and ensuring the supplier can meet potential bulk order requirements. By prioritizing quality and vendor reliability, organizations can secure a vital component for their advanced research, driving innovation in the pharmaceutical and biotechnology sectors.